Animal Venom Pharmacological Resources: Exploiting Bioactive Peptides to Target Multi–Drug‐Resistant Bacteria
Biochemistry Research International · 2026-01 · 2026 (1)
DOI: 10.1155/bri/5088674 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemistry Research International, online erschienen am 17.05.2026. Verfasst von Rima Jaber und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Applied Biotechnology (LBA3B), Azm Center for Research in Biotechnology and Its Applications, EDST, Lebanese University, 1300, Tripoli,…. Die Arbeit nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The escalating rise of multi–drug‐resistant (MDR) bacterial strains significantly threatens global health, creating a “silent pandemic” prompted by natural selection, gene mutation, and horizontal gene transfer. This crisis is worsened by the deficit in the development of new treatments, necessitating the innovative discovery of new potent antibacterial agents.
Objective
This review examines animal venom, a complex mixture of an evolutionary array of bioactive molecules, as an important emergent source of broad‐spectrum antimicrobial peptides (AMPs), creating potential drug templates for next‐generation therapeutics.
Results
We highlight numerous identified AMPs from various venomous taxa, including scorpions, snakes, spiders, frogs, bees, and wasps, characterized by their bactericidal activity against both Gram‐positive and Gram‐negative bacteria. They exhibit diverse mechanisms of action, characterized by rapid membrane disruption models, biofilm inhibition, bacterial enzyme dysregulation, immunomodulatory effects, and the control of intracellular targets. These bioresources serve as a structural base for the development of analogs with enhanced potency, higher selectivity, and less systemic toxicity. We also discuss repurposing strategies applied to the native AMPs, the potential application of nanoparticle technologies and the usage of computational methods.
Conclusion
These advanced approaches accelerate the examination of large databases to optimize structure–function characteristics, providing a roadmap for the development of future potential antimicrobial treatments derived from the rich reservoir of animal venom bioactive molecules.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Applied Biotechnology (LBA3B), Azm Center for Research in Biotechnology and Its Applications, EDST, Lebanese University, 1300, Tripoli, Lebanon, ul.edu.lb.
- University of Angers, INSERM U1083, CNRS UMR 6015, MITOVASC, SFR ICAT, F-49000, Angers, France, univ-angers.fr.
- Faculty of Health Sciences, University of Balamand, Al-Kourah P.O. Box 100, Tripoli, 1300, Lebanon, balamand.edu.lb.
- Faculty of Arts and Sciences, University of Balamand, Al-Kourah P.O. Box 100, Tripoli, 1300, Lebanon, balamand.edu.lb.
- College of Engineering and Technology, American University of the Middle East, Egaila, 54200, Kuwait, aum.edu.kw.
- Faculty of Medicine and Medical Sciences, University of Balamand, Kalhat P.O. Box 100, Tripoli, Lebanon, balamand.edu.lb.
ORCID-Profile: Rima Jaber, César Mattei, Claudine Accary, Rabih Roufayel, Ziad Abi Khattar, Ziad Fajloun
Zitieren
APA
Jaber, R., Mattei, C., Accary, C., Roufayel, R., Abi Khattar, Z., & Fajloun, Z. (2026). Animal Venom Pharmacological Resources: Exploiting Bioactive Peptides to Target Multi–Drug‐Resistant Bacteria. Biochemistry Research International, 2026(1). https://doi.org/10.1155/bri/5088674
Vancouver
Jaber R, Mattei C, Accary C, Roufayel R, Abi Khattar Z, Fajloun Z. Animal Venom Pharmacological Resources: Exploiting Bioactive Peptides to Target Multi–Drug‐Resistant Bacteria. Biochemistry Research International. 2026;2026(1). doi:10.1155/bri/5088674
BibTeX
@article{Jaber2026,
author = {Jaber, Rima and Mattei, César and Accary, Claudine and Roufayel, Rabih and Abi Khattar, Ziad and Fajloun, Ziad},
title = {Animal Venom Pharmacological Resources: Exploiting Bioactive Peptides to Target Multi–Drug‐Resistant Bacteria},
journal = {Biochemistry Research International},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/bri/5088674}
}
EUVIMED